Loading...
Chemical structure of Irinotecan hydrochloride

GC36329

Irinotecan hydrochloride

Also known as [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride

Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer

ChemicalCAS100286-90-6MW623.14FormulaC33H39ClN4O6
CAS number
100286-90-6
Molecular weight
623.14
Formula
C33H39ClN4O6
Solubility
DMSO: ≥ 51 mg/mL (81·84 mM); Water: 3·33 mg/mL (5·34 mM)
InChIKey
GURKHSYORGJETM-WAQYZQTGSA-N
Catalogue number
GC36329
Brand
GLPBIO
Computed properties PubChem CID 74990 · TPSA 113 Ų · H-bond donors 2 · H-bond acceptors 8
TPSA
113 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
5
Heavy atoms
44

SMILES CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl

Computed descriptors from PubChem (CID 74990), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.